An interventional study of one time testing in Trunk Stability, sponsored by University Ghent. Completed at 1 site in Belgium. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-12.
Sponsored by University Ghent · Not applicable, Interventional, and Basic science
Trunk stability is supposed to be an important predisposition for arm function. To the investors knowledge this is never been demonstrated.
Fifty healthy subjects will execute a reaching movement in sitting. They will reach to a cone at a distance of little more than armlength.
Electromyogram (EMG) and kinematics will be the outcome measures. Secondary outcome measures are: sex, dexterity, skillfulness, Fifty first time stroke patients will execute the same movements. Primery outcome is EMG and kinematics; secundary outcome measures are: side of hemiplegia, arm recuperation.
141 studies on the registry are indexed under Disease Susceptibility; 31 are open to participants now.
This study's enrollment of 110 is below the median of 137 across 54 interventional studies indexed under Disease Susceptibility.
Browse Disease Susceptibility studies →University Ghent is the lead sponsor of 345 studies on the registry; 85 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
healthy subjects
Other: one time testing
first time stroke patients
Electromyography to analyze muscle activation
which muscle is active during a reaching movement
Time frame: 2 hours
kinematics to analyze trunk involvement
when is the trunk involved in a reaching movement
Time frame: 2 hours
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Ghent